Stevens, William B.

CTX110 Allogeneic CRISPR-Cas9-Engineered CAR T Cells in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Phase 1 Dose Escalation Carbon Study

Ho, Phoebe Joy, Shaughnessy, Paul , Bishop, Michael, Geethakumari, Praveen Ramakrishnan , Ross, Ainsley, Stevens, William B. , Xu, Huansheng, Ma, Anna, Beaussant-Cohen, Sarah , Bachier, Carlos, McGuirk, Joseph P. , Tam, Constantine S. , Kroger, Nicolaus , Riedell, Peter A. , Murthy, Hemant S. , Maakaron, Joseph E. , Waller, Edmund K. , Awan, Farrukh T. , Ghobadi, Armin , Piérola, Ana Alfonso , Dickinson, Michael , Stevens, William, Beaussant, Sarah cohen , Maziarz, Richard Thomas

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10303-10306

10.1182/blood-2022-166432